Boothbay Fund Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,705
Closed -$334K – 2334
2026
Q1
$334K Sell
1,705
-2,336
-58% -$454K ﹤0.01% 1564
2025
Q4
$701K Buy
+4,041
New +$736K 0.01% 968
2025
Q1
– Sell
-2,940
Closed -$444K – 1489
2024
Q4
$444K Buy
+2,940
New +$457K 0.01% 922
2024
Q3
– Sell
-2,157
Closed -$295K – 1679
2024
Q2
$295K Buy
+2,157
New +$295K 0.01% 1163
2024
Q1
– Sell
-2,337
Closed -$322K – 1648
2023
Q4
$322K Buy
2,337
+569
+32% +$74.8K 0.01% 1160
2023
Q3
$215K Buy
+1,768
New +$236K 0.01% 1403
2021
Q2
– Sell
-2,154
Closed -$276K – 1903
2021
Q1
$276K Buy
2,154
+149
+7% +$18.4K 0.01% 1231
2020
Q4
$239K Buy
+2,005
New +$244K 0.01% 1030
2020
Q3
– Sell
-3,040
Closed -$346K – 1080
2020
Q2
$346K Sell
3,040
-60
-2% -$6.36K 0.02% 666
2020
Q1
$249K Buy
+3,100
New +$321K 0.02% 615
2018
Q3
– Sell
-2,538
Closed -$279K – 819
2018
Q2
$279K Sell
2,538
-518
-17% -$54K 0.02% 501
2018
Q1
$307K Sell
3,056
-308
-9% -$31.5K 0.04% 467
2017
Q4
$331K Buy
+3,364
New +$319K 0.05% 397
2017
Q3
– Sell
-3,394
Closed -$377K – 631
2017
Q2
$377K Buy
3,394
+1,323
+64% +$140K 0.08% 340
2017
Q1
$203K Sell
2,071
-2,348
-53% -$224K 0.04% 599
2016
Q4
$277K Buy
+4,419
New +$381K 0.06% 429

Other funds holding DGX

Boothbay Fund Management's DGX Position: Q2 2026 in Review

Boothbay Fund Management sold out of Quest Diagnostics (DGX) in Q2 2026, closing a stake of 1,705 shares — an estimated $334K sold.

Boothbay Fund Management first reported a position in DGX in Q4 2016 and held it in 16 quarters. The position peaked at $701K in Q4 2025. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Boothbay Fund Management reported no remaining Quest Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 1,705 Quest Diagnostics shares in Q2 2026, an estimated $334K.
  • Boothbay Fund Management first reported a position in Quest Diagnostics in Q4 2016 and held it in 16 quarters.
  • Boothbay Fund Management's Quest Diagnostics position peaked at $701K in Q4 2025.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.